← Leaderboards
George F Atweh
Mount Sinai School Of Medicine Of Cuny
$3,209,628
Attributed
$3,209,628
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $339K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$3,209,628 · 5
By mechanism
R01$1,677,150 · 2
P60$1,463,690 · 2
M01$68,788 · 1
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Cuny
Same institution · by research overlap
- Jeremy M. Silverman$5,588,266
- Jill P Crandall$14,281,706
- Millicent Sutton$460,992
- Robert J Desnick$19,687,262
- Christine Eng$10,462,016
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaThalassemiaHuman SubjectButyratesHemoglobin FClinical ResearchTissue /Cell CultureClinical TrialsHuman Therapy EvaluationGene Induction /RepressionDisease /Disorder ModelGene TherapyHematopoietic Stem CellsTransfection /Expression VectorGlobinGene ExpressionHuman Genetic Material TagRetroviridaeDisease /Disorder Prevention /ControlHematopoiesisFlow CytometryAnimal TissueCell LineGenetic Manipulation
Grant awards (16)
Reversal of Epigenetic Silencing of the G-Globin Gene$331,034
R01 · FY2006 · HL · contact PI
Reversal of Epigenetic Silencing of the G-Globin Gene$339,000
R01 · FY2005 · HL
Reversal of Epigenetic Silencing of the G-Globin Gene$339,000
R01 · FY2004 · HL
Reversal of Epigenetic Silencing of the G-Globin Gene$339,000
R01 · FY2003 · HL
IN VITRO MODELS OF SICKLE CELL GENE THERAPY$198,780
P60 · FY2002 · HL
IN VITRO MODELS OF SICKLE CELL GENE THERAPY$198,780
P60 · FY2002 · HL
INDUCTION OF FETAL HEMOGLOBIN WITH ARGININE BUTYRATE$198,780
P60 · FY2002 · HL
INDUCTION OF FETAL HEMOGLOBIN WITH ARGININE BUTYRATE$198,780
P60 · FY2002 · HL
CLINICAL TRIAL OF IV BUTYRATE IN FETAL HEMOGLOBIN BETA GLOBIN DISORDERS$0
M01 · FY2002 · RR
IN VITRO MODELS OF SICKLE CELL GENE THERAPY$198,780
P60 · FY2001 · HL
INDUCTION OF FETAL HEMOGLOBIN WITH ARGININE BUTYRATE$198,780
P60 · FY2001 · HL
CLINICAL TRIAL OF IV BUTYRATE IN FETAL HEMOGLOBIN BETA GLOBIN DISORDERS$0
M01 · FY2001 · RR
RETROVIRAL MEDIATED GLOBIN GENE THERAPY$329,116
R01 · FY2000 · HL
IN VITRO MODELS OF SICKLE CELL GENE THERAPY$135,505
P60 · FY2000 · HL
INDUCTION OF FETAL HEMOGLOBIN WITH ARGININE BUTYRATE$135,505
P60 · FY2000 · HL
CLINICAL TRIAL OF IV BUTYRATE IN FETAL HEMOGLOBIN BETA GLOBIN DISORDERS$68,788
M01 · FY2000 · RR